Literature DB >> 20008269

Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation.

Li Meng1, Jehyun Park, Qiangjun Cai, Linda Lanting, Marpadga A Reddy, Rama Natarajan.   

Abstract

Diabetes is associated with significantly accelerated rates of atherosclerosis, key features of which include the presence of excessive macrophage-derived foam cells in the subendothelial space. We examined the hypothesis that enhanced monocyte-vascular smooth muscle cell (VSMC) interactions leading to subendothelial monocyte retention and differentiation to macrophages under diabetic conditions may be underlying mechanisms. Human aortic VSMCs (HVSMCs) treated with diabetic stimuli high glucose (HG) or S100B, a ligand of the receptor for advanced glycation end products, exhibited significantly increased binding of THP-1 monocytic cells. Diabetic stimuli increased the expression of the adhesive chemokine fractalkine (FKN) in HVSMCs. Pretreatment of HVSMCs with FKN or monocyte chemoattractant protein-1 (MCP-1) neutralizing antibodies significantly inhibited monocyte-VSMC binding, whereas monocytes treated with FKN showed enhanced binding to VSMC. Mouse aortic VSMCs (MVSMCs) derived from type 2 diabetic db/db mice exhibited significantly increased FKN levels and binding to mouse WEHI78/24 monocytic cells relative to nondiabetic control db/+ cells. The enhanced monocyte binding in db/db cells was abolished by both FKN and MCP-1 antibodies. Endothelium-denuded aortas from db/db mice and streptozotocin-induced diabetic mice also exhibited enhanced FKN expression and monocyte binding, relative to respective controls. Coculture with HVSMCs increased CD36 expression in THP-1 cells, and this was significantly augmented by treatment of HVSMCs with S100B or HG. CD36 mRNA and protein levels were also significantly increased in WEHI78/24 cells after coincubation with db/db MVSMCs relative to control MVSMCs. These results demonstrate that diabetic conditions may accelerate atherosclerosis by inducing key chemokines in the vasculature that promote VSMC-monocyte interactions, subendothelial monocyte retention, and differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008269      PMCID: PMC2838549          DOI: 10.1152/ajpheart.00935.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  54 in total

Review 1.  Pathologies involving the S100 proteins and RAGE.

Authors:  C W Heizmann; G E Ackermann; A Galichet
Journal:  Subcell Biochem       Date:  2007

Review 2.  Getting to the site of inflammation: the leukocyte adhesion cascade updated.

Authors:  Klaus Ley; Carlo Laudanna; Myron I Cybulsky; Sussan Nourshargh
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

Review 3.  Clinical review: The role of advanced glycation end products in progression and complications of diabetes.

Authors:  Su-Yen Goh; Mark E Cooper
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

4.  Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice.

Authors:  Shu-lian Li; Marpadga A Reddy; Qiangjun Cai; Li Meng; Hang Yuan; Linda Lanting; Rama Natarajan
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

5.  Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.

Authors:  Noah Saederup; Liana Chan; Sergio A Lira; Israel F Charo
Journal:  Circulation       Date:  2007-12-28       Impact factor: 29.690

Review 6.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Authors:  Amanda C Doran; Nahum Meller; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

7.  Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.

Authors:  Evis Harja; De-xiu Bu; Barry I Hudson; Jong Sun Chang; Xiaoping Shen; Kellie Hallam; Anastasia Z Kalea; Yan Lu; Rosa H Rosario; Sai Oruganti; Zana Nikolla; Dmitri Belov; Evanthia Lalla; Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

8.  Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.

Authors:  Louisa M Villeneuve; Marpadga A Reddy; Linda L Lanting; Mei Wang; Li Meng; Rama Natarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

9.  Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function.

Authors:  Yuko Ishida; Ji-Liang Gao; Philip M Murphy
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

Review 10.  Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-03-11
View more
  18 in total

1.  Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms.

Authors:  Matthew R Alexander; Meera Murgai; Christopher W Moehle; Gary K Owens
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

Review 2.  Epigenetic mechanisms in diabetic vascular complications.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  Cardiovasc Res       Date:  2011-01-25       Impact factor: 10.787

3.  Glycated albumin modulates endothelial cell thrombogenic and inflammatory responses.

Authors:  David A Rubenstein; Zahra Maria; Wei Yin
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

4.  Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.

Authors:  Chang Hyun Byon; Tieyan Han; Judy Wu; Simon T Hui
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

5.  Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice.

Authors:  Marpadga A Reddy; Wen Jin; Louisa Villeneuve; Mei Wang; Linda Lanting; Ivan Todorov; Mitsuo Kato; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-12       Impact factor: 8.311

6.  The effects of sodium tanshinone IIa sulfonate pretreatment on high glucose-induced expression of fractalkine and apoptosis in human umbilical vein endothelial cells.

Authors:  Fa-Qi Li; De-Kang Zeng; Chao-Li Jia; Ping Zhou; Ling Yin; Bin Zhang; Fang Liu; Qing Zhu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 7.  Cardiovascular disease in diabetes: where does glucose fit in?

Authors:  Jane E B Reusch; Cecilia C Low Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

Review 8.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

9.  Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.

Authors:  K H Song; J Park; J H Park; R Natarajan; H Ha
Journal:  Diabetologia       Date:  2013-04-19       Impact factor: 10.122

10.  Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.

Authors:  Marpadga A Reddy; Sadhan Das; Chen Zhuo; Wen Jin; Mei Wang; Linda Lanting; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.